Discreet Ketamine
Medical Practices • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 62 |
| Keywords | Medical, Addiction, Depression, Trauma, Anxiety, OCD, Ptsd, Holistic Therapy, Mental Health, Medical Health, Psychedelic Therapy, Ketamine Therapy, Online Ketamine, Oral Ketamine Treatment |
| Founded | 2023 |
| Employees | 1-10 |
Key Contact at Discreet Ketamine
Benjamin Soffer
Medical Director
About Discreet Ketamine
Ketamine oral treatment combined with counseling sessions to address treatment resistant depression, anxiety, PTSD and chronic pain in the comfort and privacy of your own home and bed. Ketamine has demonstrated notable efficacy in treating treatment-resistant anxiety and depression, supported by various scientific studies. Clinical trials and research have shown that ketamine, primarily administered via intravenous infusion or as an oral dissolving tablet, can provide rapid and significant reduction in symptoms for individuals who have not responded to traditional treatments for anxiety and depression. Ketamine induces a state similar to deep meditation, altering thought patterns and inducing a heightened sense of spirituality and openness to profound feelings. Ketamine is an anesthetic and potent pain reliever, reducing acute and chronic pain.
Discreet Ketamine revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Practices industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Discreet Ketamine has never raised funding before.
United Kingdom
Spain
Portugal
France
Italy
South AfricaFrequently asked questions
4.8
40,000 users
